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Abstract
Background: Oxidative stress plays a key role in exacerbating diabetes and cardiovascular disease. Heme oxygenase-1 (HO-
1), a stress response protein, is cytoprotective, but its role in post myocardial infarction (MI) and diabetes is not fully
characterized. We aimed to investigate the protection and the mechanisms of HO-1 induction in cardiomyocytes subjected
to hypoxia and in diabetic mice subjected to LAD ligation.
Methods: In vitro: cultured cardiomyocytes were treated with cobalt-protoporphyrin (CoPP) and tin protoporphyrin (SnPP)
prior to hypoxic stress. In vivo: CoPP treated streptozotocin-induced diabetic mice were subjected to LAD ligation for 2/
24 h. Cardiac function, histology, biochemical damage markers and signaling pathways were measured.
Results: HO-1 induction lowered release of lactate dehydrogenase (LDH) and creatine phospho kinase (CK), decreased
propidium iodide staining, improved cell morphology and preserved mitochondrial membrane potential in cardiomyocytes.
In diabetic mice, Fractional Shortening (FS) was lower than non-diabetic mice (3561%vs.4162, respectively p,0.05). CoPP-
treated diabetic animals improved cardiac function (4362% p,0.01), reduced CK, Troponin T levels and infarct size
compared to non-treated diabetic mice (P,0.01, P,0.001, P,0.01 respectively). CoPP-enhanced HO-1 protein levels and
reduced oxidative stress in diabetic animals, as indicated by the decrease in superoxide levels in cardiac tissues and plasma
TNFa levels (p,0.05). The increased levels of HO-1 by CoPP treatment after LAD ligation led to a shift of the Bcl-2/bax ratio
towards the antiapoptotic process (p,0.05). CoPP significantly increased the expression levels of pAKT and pGSK3b
(p,0.05) in cardiomyocytes and in diabetic mice with MI. SnPP abolished CoPP’s cardioprotective effects.
Conclusions: HO-1 induction plays a role in cardioprotection against hypoxic damage in cardiomyocytes and in reducing
post ischemic cardiac damage in the diabetic heart as proved by the increased levels of pAKT with a concomitant inhibition
of pGSK3b leading to preserved mitochondrial membrane potential.
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Introduction
Ischemia-induced cell necrosis and apoptosis are major
contributors to cardiac dysfunction in ischemic heart disease It is
recognized that mitochondrial dysfunction plays a crucial role in
the pathogenesis of cell death induced by myocardial ischemia [1].
The change in mitochondrial permeability has been attributed to
the formation and opening of a nonspecific mitochondrial
permeability transition pore (mPTP) [2,3]. The key factor
responsible for mPTP opening is mitochondrial calcium overload,
especially when this is accompanied by oxidative stress, adenine
nucleotide depletion, elevated phosphate concentrations, and
mitochondrial depolarization [4,5,6].
Heme oxygenase-1 (HO-1), a stress response protein, is the rate-
limiting enzyme in the catabolism of heme to free iron, carbon
monoxide (CO), and biliverdin, which is rapidly converted to
bilirubin. HO-1 plays an important role in cellular protection
against oxidative insult in cardiovascular disease, including
diabetes, and in the alleviation of vascular diseases. Current
knowledge highlights the importance of HO-1, specifically within
the heart, due to the action of the products of heme degradation.
Excess heme, due to its pro-oxidant and pro-inflammatory
properties, contributes to an increase in free radical formation
and cell injury [7]. Heme degradation generates biliverdin and
bilirubin, which possess potent antioxidant properties [8] and are
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cytoprotective in the cardiovascular system [9]. HO-1 plays an
important role in maintaining redox status within the heart,
thereby protecting against oxidative insult. HO-1 gene expression
reverses ischemic heart injury [10] and prevents vascular
dysfunction in experimental diabetes [11]. We have reported that
diabetic patients have lower levels of HO-1 and elevated levels of
inflammatory and oxidative stress markers [12].
HO-1 induction alters the morphology of adipocytes from a few
large to many small adipocytes. These smaller adipocytes exhibit
increases in AMPK and adiponectin (Acrp30), while exhibiting the
decreased production of inflammatory markers and cytokines
(including TNFa) [13]. Unlike most other adipokines, the plasma
level of adiponectin is reduced in obesity, diabetes and related
pathologies [14,15]. In animals models, administration of recom-
binant adiponectin protects against almost all the major obesity-
related disorders, including insulin resistance [16], hypertension
[17], atherosclerosis [18], and HF [19]. Adiponectin can directly
affect signaling in myocardial cells and exerts beneficial activities
on the heart after pressure overload and ischemia–reperfusion
injury [20,21,22].
In this study we elucidate the protective effects of CoPP
pretreatment against hypoxic-induced cardiomyocyte damage. We
also hypothesized that the induction of HO-1 in diabetic mice
subjected to LAD ligation improves heart function and reduce
damage. We report here that increased levels HO-1 decrease
hypoxic damage in cardiomyocytes and improved heart function
in diabetic mice subjected to MI. In addition, HO-1 induction
increased the levels of the AKT prosurvival pathway. This was
associated with GSK-3b inhibition, which preserved mitochon-
drial membrane potential (DYm) in hypoxic stress in cardiomy-
ocytes.
Materials and Methods
Animals and experimental protocol
All experiments were approved by the Institutional Animal Care
and Use Committee at Tel Aviv University, with the Guide for the
Care and Use of Laboratory Animals published by the US
National Institutes of Health. Male wild type mice (C57BL) were
purchased from Harlan (Jerusalem, Israel). Mice were housed in a
temperature-controlled atmosphere, 12/12-hour light/dark cycle
and had access to standard laboratory chow and water. The
experiments were performed on 2–3 month-old male mice. CoPP
(0.5 mg/100 g body) or the corresponding vehicle was given i.p.
48 h before LAD ligation. SnPP (2 mg/100 g body) or the
corresponding vehicle was administered i.p. 24 h before LAD
ligation. Mice were divided into 6 groups (MI and sham in each
group): control mice, diabetic mice, diabetic mice + CoPP and
diabetic mice + CoPP + SnPP (n= 6 mice in each group). MI or
sham operation was conducted as previously described [23], using
the model of left descending (LAD) coronary artery ligation. All
surgery was performed under anesthesia. Mice were anesthetized
(with a mixture of 100 mg/kg ketamine and 10 mg/kg xylazine)
and animals were intubated and connected to a mechanical
respirator. The chest was opened by a left thoracotomy and the
heart was exposed. MI was induced by permanent ligation of the
LAD. Sham operations were carried out by the same method but
without tying the suture on the LAD. Using isoflurane anesthesia
mice were sacrificed 2 h or 24 h post-surgery for blood and heart
samples analyses (Fig 1). All efforts were made to minimize
animals’ suffering.
Cell culture
Rat hearts (Sprague–Dawley 1–2 days old) were removed under
sterile conditions and washed three times in phosphate-buffered
saline (PBS) to remove excess blood cells. The hearts were minced
and then gently agitated in a solution of proteolytic enzymes -RDB
(Biological Institute, Ness-Ziona, Israel), which was prepared from
fig tree extract. RDB was diluted 1:100 in Ca2+ and Mg2+ free PBS
for a few cycles of 10 min each, as described previously [24].
Dulbecco’s modified Eagle’s medium (Biological Industries,
Kibbutz Beit Haemek, Israel) containing 10% horse serum was
added to supernatant suspensions containing dissociated cells. The
mixture was centrifuged at 300 g for 5 min. The supernatant
phase was discarded, and the cells were resuspended. The
suspension of the cells was diluted to 1.06106 cells/ml, and
1.5 ml of the suspension was placed in 35-mm plastic culture
dishes, or on collagen/gelatin coated cover glasses. The cultures
were incubated in a humidified atmosphere of 5% CO2 and 95%
air at 37uC. Confluent monolayers exhibiting spontaneous
contractions were developed in culture within 2 days. All
experiments were approved by the Institutional Animal Care
and Use Committee at Tel Aviv University, with the Guide for the
Care and Use of Laboratory Animals published by the US
National Institutes of Health.
Hypoxic conditions
Cardiomyocyte cultures were washed in serum- and glucose-
free medium before being subjected to hypoxic conditions.
Exposure to argon (100%) for 120 min in a hypoxic chamber in
glucose-free medium was used to simulate ischemic conditions in
primary cardiac myocyte cultures. At the end of the hypoxic
period, damage was evaluated using morphological and biochem-
ical assessments.
Experiments with CoPP and SnPP
CoPP (20 mm) or the corresponding vehicle was added to the
cardiomyocyte cultures 24 h prior to hypoxia. SnPP (30 mm) or
the corresponding vehicle was added 2 h after CoPP. CoPP and
SnPP were purchased from Frontier Science (Logan, UT, USA)
and dissolved in 0.1 M sodium citrate buffer, pH 7.8.
Lactate dehydrogenase (LDH) and creatine kinase (CK)
measurement in Cardiomyocyte culture
LDH/CK activity was determined as previously described [24].
Briefly, 25 mL growing medium was transferred into a 96-well
plate and LDH/CK activity was determined with an LDH-L/CK
kit (Thermo Electron, Melbourne, Australia). The product of the
enzyme was measured spectrometrically at 30uC at a wavelength
of 340 nm.
Propidium iodide (PI) staining in cardiomyocyte culture
The assay is based on binding of propidium iodide (PI) to the
nuclei of cells the plasma membranes of which have become
permeable due to cell damage. Cell viability was determined by PI
fluorometry using a multi-well plate reader (TECAN SpectraFluor
Plus, Austria) and incubated for 30 min at 37uC. Fluorescence (A)
Figure 1. experimental protocol: Schematic illustration of the
protocols used in the in vivo experiments.
doi:10.1371/journal.pone.0092246.g001
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from each plate/well was measured at excitation and emission
wavelengths of 540 and 630 nm, respectively. The background
fluorescence (B) was assessed from an unstained plate. Experiments
were terminated by permeabilizing plasma membranes with
300 mM digitonin to label all nuclei with PI. A final fluorescence
(C) was measured 30 min after digitonin treatment. The
percentage of damaged cells (V) was calculated as
V= 100(A2B)/(C2B) [25].
Hematoxylin and eosin staining in cardiomyocyte culture
After exposure to hypoxic conditions, cardiomyocytes in the cell
cultures were fixed for 10 min with 100% methanol. The fixed
cells were washed twice with PBS and incubated for 15 min with
hematoxylin. The stained cells were rinsed in running tap water,
and stained with eosin for 15 min. The cells were then rinsed
again in tap water, dehydrated and mounted on a Zeiss
microscope.
Mitochondrial membrane potential measurement
Cardiomyocyte cell cultures, grown on round coverslips, were
exposed to 2-(4-(dimethylamino)styryl)-1-methylpyridinium iodide
(4-di-1-ASP = DASPMI), dissolved in PBS (10 mmol/L) for
15 min. The coverslips were washed in PBS. The fluorescence
intensity was examined under fluorescence microscopy and by a
Tecan fluorimeter at 460/540 nm wavelengths. Image J software
was used for quantifying DASPMI staining [26].
Diabetes induction and monitoring
To induce diabetes in mice, we administered a single i.p.
injection of 50 mg/kg streptozotocin (STZ). STZ was freshly
dissolved in cold citrate buffer (pH=4.5). Mice began fasting 6 h
before STZ injection. Blood glucose level (BGL) was determined
by withdrawing blood from the tail vein and measuring it with a
glucose meter (Roche Accu-Chek, Basel, Switzerland).
Two dimensional M mode echocardiography
Animals were lightly anesthetized by inhaling isoflurane. Two-
dimensional (2D) guided M-mode echocardiography was per-
formed using an echocardiogram (Siemens 512, Sequoia, U.S.A)
equipped with a 15-MHz linear transducer at baseline and
following LAD ligation. The 2D mode in the parasternal long-axis
view was used to monitor the heart. From this view, an M mode
cursor was positioned perpendicular to the interventricular septum
and posterior wall of the left ventricle (LV) at the level of the
papillary muscles. An M mode image was obtained at a sweep
speed of 100 mm/s. Left-ventricular end-diastolic dimensions
(LVEDD), and left-ventricular end-systolic chamber dimensions
(LVESD) were measured. Fractional shortening (FS) was calcu-
lated as: [LVEDD – LVESD)/LVEDD]x100 (23).
Assessment of infarct size
Midventricular viable heart sections were put in a 1% solution
of 2,3, 5-triphenyl tetrazolium chloride (TTC) in phosphate buffer
for 10 min at 37uC. TTC stained the viable tissue with red while
the necrotic tissue remained discolored. Sections were fixed
overnight in 4% formaldehyde to enhance the contrast between
stained and unstained tissue. The sections were then placed
between two cover slips and digitally photographed using a Nikon
coolpix 5000 camera, at a resolution of 14006960 pixels, and
quantified by using ImagePro PLUS software (Media Cybernetics,
USA). The area of irreversible injury (TTC-negative) is presented
as a percentage of the entire area of the section [27].
Western blotting
Frozen hearts were pulverized under liquid nitrogen and placed
in a homogenization buffer (10 mmol/l phosphate buffer,
250 mmol/l sucrose, 1 mmol/l EDTA and 0.1 mmol/l phenyl-
methylsulfonyl fluoride (PMSF), pH 7.5). Myocytes from cell
cultures were homogenized in lysis buffer and quantified for
protein levels using a commercial assay (Bio-Rad, Israel).
Homogenates were centrifuged at 27,000 g for 10 minutes at
4uC, the supernatant was isolated, and protein levels were
visualized by immunoblotting with antibodies. Briefly, proteins
(50 mg/sample) were separated using sodium dodecyl sulfate (SDS)
polyacrylamide gel (12%) under denaturing conditions and
electrotransferred onto nitrocellulose (Bio-Rad) for 1 h at 100 V.
Membranes were blocked with 5% nonfat milk in Tris–buffered
saline with 0.1% Tween 20 (TBST) for 1 h at room temperature.
Primary antibodies were used at a 1:1000 concentration in TBST
with 5% nonfat milk overnight at 4uC. HO-1,AKT and BCL-2
were obtained from Cell Signaling Technology, Inc (Beverly MA,
USA) and glycogen synthase kinas-beta (GSK3-b) was obtained
from Santa Cruz Biotechnology (Santa Cruz, California, USA).
Immunodetection of Actin/GPDH (LI-COR Biosciences, NE,
USA) was performed as an internal control. Dye 800/680
secondary antibodies were added at a concentration of 1:15000
for 1 h at room temperature. Quantification of signals was carried
out with the Odyssey program (Li CORE, Lincoln, NE, USA).
Biochemical analysis of mice plasma
Levels of troponin T were determined in the serum using
Cardiac T 2017423, Roche kit (Indianapolis, USA). Levels of CK
were determined in the serum using commercial Olympus
OSR6126 kit (Center Valley, PA, USA). TNF-a protein levels in
the serum were assessed using ELISA semi-kits for mouse TNF-a
(ELISA-Max, BioLegend, CA, USA).The high molecular weight
(HMW) form of adiponectin was determined using ELISA assays
(Pierce Biotechnology, Inc., Woburn, MA).
Measurement of heart superoxide levels
Heart homogenates were placed in plastic scintillation minivials
containing 5 mmol/l lucigenin for the detection of O2 in a final
volume of 1 ml air-equilibrated Krebs solution (pH 7.4) buffered
with 10 mmol HEPES-1M NaOH as described previously [28].
Lucigenin chemiluminescence was measured using a liquid
scintillation counter (LS6000IC, Beckman Instruments, San
Diego, CA, USA).
Statistical analysis
Statistical differences between the mice groups were assessed by
analysis of variance (ANOVA) with post hoc Bonferroni test. Data
are presented as mean 6SD. Statistical significance was
determined as p,0.05. The analyses were performed using SPSS
version 15 statistical software (SPSS Inc., Chicago, IL, USA).
Results
The effects of HO-1 induction on cardiomyocytes
exposed to hypoxia
The release of LDH and CK was used as an index of
cardiomyocyte injury. Untreated hypoxic cells released increased
amounts of LDH (953616.1%) and CK (690619.1%) relative to
normoxic cells (100%), (p=0.01). CoPP suppressed the release of
LDH in cardiomyocytes that had undergone exposure to hypoxia.
LDH levels decreased to 364620% and CK to 209620% of
normoxia (p=0.01). SnPP abolished the beneficial effect of CoPP-
HO-1 Induction Improves Ischemic Cardiac Function
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pretreatment and the release of LDH and CK was similar to that
of the untreated hypoxic group (918623% and 70067%
respectively, (Table 1), (p=0.01). CoPP and SnPP did not cause
cell damage when administered under normoxic conditions (data
not shown).
The effect of HO-1 induction on cardiomyocyte viability
and morphology following hypoxia
Following 2 h of hypoxia in cardiomyocytes, hematoxylin and
eosin staining demonstrated typical irreversible oncotic damage of
untreated cardiomyocytes subjected to hypoxia compromising
vacuoles, myofilaments disorder, and edematous areas in the
cytoplasm and around the nucleus (Fig. 2A hypoxia). CoPP
preserved the morphological appearance of the cardiomyocytes
subjected to hypoxia, maintained symmetry of the myofilaments,
retained a globular nucleus, and a clear border of the cell
membrane, similar to the morphology of normoxic cells (Fig. 2A
hypoxia + CoPP). SnPP administration eliminated the beneficial
effect of CoPP-pretreatment resulting in cell morphology similar to
that of the untreated hypoxic group (Fig 2A hypoxia + CoPP+
SnPP). Hypoxia of untreated cardiomyocytes caused cell damage
of 17.762.2%, as revealed by PI binding, whereas under
normoxic conditions PI binding was 2.1460.55% (p=0.01).
CoPP significantly (p,0.01) increased the viability of cardiomy-
ocytes injured by hypoxia (4.861.7%). SnPP abolished the
beneficial effect of CoPP-pretreatment with a resultant cell
damage of 15.660.33% hypoxic levels (Fig. 2B, p=0.01.). The
protective effect was also demonstrated morphologically.
The effect of HO-1 induction on mitochondrial
membrane potential in cardiomyocytes following
hypoxia
In order to evaluate mitochondrial function following hypoxic
stress cardiomyocytes were stained with DASPMI to estimate
mitochondrial membrane potential. In normoxic cardiomyocytes
DASPMI fluorescence was bright yellow and distributed in the
cytosol. In many cells, localization of the mitochondria followed
the striation pattern of the myofibrils. Under hypoxic conditions,
untreated hypoxic cardiomyocytes exhibited low mitochondrial
membrane potential. The intermyofibrillar mitochondrial patterns
disappeared almost completely and a dim yellow fluorescence,
mainly around the nucleus, remained (Fig. 2C Hypoxia).
Pretreatment with CoPP before hypoxia protected the mitochon-
dria from the loss of Dy (Fig. 2C hypoxia + CoPP). This protective
effect on the mitochondrial membrane potential was blocked by
SnPP. Results of microfluorometric quantification of DASPMI
staining are shown in Fig. 2C.
The effect of CoPP treatment on the expression of
endogenous HO-1 and AKT pathway in cardiomyocytes
following hypoxia
We evaluated the levels of HO-1 via Western blot analysis in
response to CoPP treatment after 2 h exposure to hypoxic stress.
HO-1 levels were higher in hypoxia compared to normoxia cells
(p,0.05). CoPP increased HO-1 3-fold in hypoxia compared to
the non-treated cells (p,0.005). SnPP did not decrease the levels of
HO-1. AKT phosphorylation was increased by hypoxia compared
to normoxic cells (p,0.01). CoPP further raised the phosphory-
lation of AKT compared to non-treated cells (p,0.05). SnPP
reduced AKT phosphorylation (p,0.05). Total AKT (T-AKT)
levels were similar in all groups Figure 3B. The elevated levels of
phosphorylated AKT in the CoPP treated cells were accompanied
by increased phosphorylation of its downstream target, GSK3-b
(Fig. 3C). CoPP significantly (p,0.01) increased GSK-3b phos-
phorylation at Ser9 suggesting that CoPP treatment can inactivate
GSK-3b in cardiac cells. Phosphorylation at this site inhibits the
activation of GSK3-b thereby leading to decreased mPTP
mitochondrial pores opening. SnPP reversed the action of CoPP
on GSK-3b phosphorylation (Fig. 3C).
Assessment of LV remodeling post-MI: echocardiography
At baseline and with the sham operation, there were no
differences between the groups in the echocardiographic mea-
surements of either cardiac dimensions or function (data not
shown). Induction of MI resulted in a pronounced increase of the
left ventricular end-systolic diameters in the diabetic mice
compared to non-diabetic mice (0.1860.015 vs 0.1560.018 cm
respectively, p,0.05). This increase was reversed by CoPP
treatment 48 hours before LAD ligation (0.14560.02 cm). Adding
SnPP slightly changed to 0.1760.021 cm but it did not reach
statistical significance (Fig. 4A). LV fractional shortening (FS) data
are shown in Figure 4B. Diabetic mice subjected to myocardial
ischemia demonstrated a significant decrease in LV FS when
compared to the non-diabetic mice (3561% vs. 4162, respec-
tively, p,0.05). CoPP increased FS in diabetic mice compared to
the untreated diabetic ones (4362%, p,0.01). SnPP abolished this
banished effect (38.561.3%,).
The effect of CoPP on cardiac damage in mice subjected
to LAD ligation
Creatine phosphokinase (CK) and cardiac Troponin T (TRP-T
specific marker denoting damage in the heart muscle) were
assessed. Increased levels of CK and cardiac Troponin T were
detected in the serum 24 h following LAD ligation compared to
sham operated mice (827.56134 VS 80654 u/l and 10.0162.5
Table 1. Measurements of biochemical markers in CoPP-pretreated cardiomyocytes subjected to hypoxia.
CK (% of normoxia level) LDH (% of normoxia level)
100 100 Normoxia
690619.1$ 953616.1 $ Hypoxia
209620# 364620# Hypoxia + CoPP
70067* 918616.1* Hypoxia + CoPP +SnPP
The release of LDH and CK after 2 h of hypoxia was lower in the group treated with CoPP compared with the untreated group. SnPP administration abolished the
beneficial effect of CoPP pretreatment. The value of 100% was given to the level of LDH or CK released from untreated cells not subjected to hypoxia. Data are means of
at least 3 replicates in 5 separate experiments. Values are means 6 SD (LDH
$
p,0.01 vs. normoxia, #p,0.01 vs. hypoxia, *p,0.01 vs. hyp +CoPP, CK$p,0.01 vs.
normoxia, #p,0.01 vs. hypoxia, *p,0.01 vs. hyp +CoPP).
doi:10.1371/journal.pone.0092246.t001
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vs. 0.3160.12 u/l respectively p,0.005). Diabetic mice treated
with CoPP 48 h before LAD ligation exhibited lower levels of CK
and Troponin T compared to non-treated diabetic mice (1134695
vs.17976220 u/l and 10.0261.5 vs. 13.4861.48 u/l respectively
p,0.005). SnPP reversed these effects (15836103 u/l,
13.5261.1 u/l respectively p=0.05). We also examined the effects
of CoPP and STZ-diabetes on the extent of myocardial injury
induced by MI. Isolated hearts were stained with TTC to identify
the infarct area size. CoPP significantly reduced infarct size in
diabetic mice compared to the non-treated diabetic mice, 24 h
after infarction (Fig. 5C, p,0.05).
The effect of CoPP on the expression of HO-1 and p-AKT
in diabetic mice
Western blot analysis showed that the expression of endogenous
HO-1 was lower in the sham operated compared to the MI mice
(p,0.005). CoPP treatment increased the expression of HO-1 in
diabetic mice compared to those of non-treated diabetic mice
(p,0. 01). SnPP did not lower the levels of HO-1 (Fig. 6A). CoPP
treatment 48 h before LAD ligation raised p-AKT levels
compared to those of the untreated diabetic mice. Administration
of SnPP 24 hours after CoPP and 24 h before LAD ligation
decreased the expression of p-AKT compared to the CoPP treated
diabetic mice (Fig. 6B, p,0.05). SnPP decreased AKT phosphor-
ylation (p,0.05). The elevated levels of phosphorylated AKT in
the CoPP treated mice were also accompanied by an increase in
phosphorylation of GSK3-b (Fig. 6C).
The effect of CoPP on Bcl-2 and Bax ratio in the heart of
diabetic mice
To capture the anti-apoptotic effect of CoPP-induced expres-
sion of HO-1 in the heart of diabetic mice, we examined the
expression of survival-promoting Bcl-2. As shown in Figure 7,
Western blot analysis revealed that the expression of Bcl-2 was
Figure 2. CoPP increases Cell viability and preservedmitochondrial membrane potential in cardiomyocytes culture. A: Morphology of
CoPP-pretreated cardiomyocytes Treatment with CoPP preserved an improved morphological appearance of the cardiomyocytes after 2 h of hypoxia
compared with the untreated group. SnPP administration abolished the beneficial effect of CoPP-pretreatment. Scale bar, 20 mm. B: The viability of
CoPP-treated cardiomyocytes subjected to hypoxia Cultured cardiomyocytes were subjected to 2 h hypoxia with or without CoPP. The cells were
stained with propidium iodide (PI), which marks damaged cells. The number of dead cells was lower in the group treated with CoPP compared with
the untreated group. SnPP reduced the beneficial effect of CoPP-pretreatment. Data are means of at least 3 replicates in 3 separate experiments.
Values are means 6 SD ($p,0.01 vs. normoxia #p,0.01 vs. hypoxia, *p,0.01 vs. hyp +CoPP). C: Mitochondrial function of CoPP-treated
cardiomyocytes Rat cultured cardiomyocytes were subjected to 2 h hypoxic conditions with or without CoPP. D: The cells were stained with DASPMI.
Hypoxic cells treated with CoPP exhibited normal mitochondrial membrane potential. SnPP administration reduced the beneficial effect of CoPP.
Data are means of at least three replicates in three separate experiments. Values are means 6 SD ($p,0.01 vs. normoxia #p,0.01 vs. hypoxia,
*p,0.01 vs. hyp +CoPP, magnification *40).
doi:10.1371/journal.pone.0092246.g002
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lower in the sham group compared to the MI group. No statistical
difference was noted in the expression of Bcl-2 between the non-
diabetic and the diabetic mice. A higher level of Bcl-2 protein
expression was detected in the CoPP treated diabetic compared to
the non-treated diabetic mice. The administration of SnPP
reduced the expression to levels similar to that of the untreated
diabetic group. This result indicates that induced HO-1 contrib-
utes to the activation of Bcl-2. In contrast, Bax expression was
similar in all the groups. CoPP treatment slightly lowered Bax
expression but it did not reach statistical significance. Since Bcl-2 is
an anti-apoptotic and Bax a pro-apoptotic gene, their ratio is a
profound indicator of cell survival; this survival ratio can be altered
either by increased Bcl-2 expression or decreased Bax expression.
The increased levels of HO-1 by CoPP treatment after LAD
ligation led to a shift of the Bcl-2/bax ratio towards the
antiapoptotic Bcl-2. CoPP treatment increased the Bcl-2/Bax
ratio by as much as 50% in the treated group compared to the
untreated diabetic and control groups (4.6860.25, 3.0560.09,
3.160.48 respectively p,0.05).
The effect of CoPP on oxidative stress in the heart of
diabetic mice
Hearts from non-treated diabetic mice showed an increase in
superoxide levels as compared to non-diabetic animals
(12.2560.55 vs.8.3160.43 cpm6 10‘4/mg protein respectively,
Fig. 8A, p,0.01). CoPP treated diabetic mice showed a decrease
in superoxide levels as compared to untreated animals (7.4360.15,
p,0.01). SnPP increased superoxide levels to those of the diabetic
groups. (11.3760.21, p,0.01). TNFa levels were increased in
diabetic mice compared to controls (40.7665.4 vs.23.9563.2 pg/
ml respectively, p,0.05) and were decreased by CoPP
(10.8664.34 pg/ml p= 0.01). SnPP raised the TNFa levels
Figure 3. CoPP increases HO-1,AKT and GSK3b expression in cardiomyocytes culture. A: Western blot analysis of HO-1 protein in the
cardiomyocyte subjected to hypoxia CoPP treatment increased HO-1 expression levels in cells subjected to hypoxia compared to non-treated cells
subjected to hypoxia. Means 6 SD, n = 3 in 3 different experiments (*p,0.05 vs. normoxia, #p,0.005 vs. hypoxia). B: Western blot analysis of AKT
protein in the cardiomyocytes subjected to hypoxia: CoPP treatment increased AKT phosphorylation in cells subjected to hypoxia compared to non-
treated cells subjected to hypoxia Means6 SD, n = 3 in 3 different experiments. (*p,0.01 vs. normoxia, #p,0.05 vs. hypoxia, $p,0.05 vs. hyp+CoPP).
C: Western blot analysis of pGSK3b protein in the cardiomyocytes subjected to hypoxia CoPP treatment increased GSK3b phosphorylation in cells
subjected to hypoxia compared to non-treated cells subjected to hypoxia. Means 6 SD, n= 3 in 3 different experiments (*p,0.01 vs. normoxia,
#p,0.01 vs. hypoxia, $p,0.05 vs. hyp+CoPP).
doi:10.1371/journal.pone.0092246.g003
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compared to the CoPP treated diabetic mice (31.5262.7 pg/ml
p= 0.01, Fig. 8B). In contrast, diabetic mice with LAD and treated
with CoPP exhibited an increase in circulating adiponectin levels
compared to diabetic groups (6.5360.65vs.1.7960.48 mg/ml
respectively). These beneficial effects were reversed by SnPP
(Fig. 8C).
Discussion
Cardiovascular disease (CVD) is a leading cause of death and
disability among diabetic patients worldwide. Increased oxidative
stress and inflammatory biomarkers play an important role in the
initiation and progression of atherosclerotic vascular disease [29].
HO-1 plays a central role in myocardial protection from hypoxia
injury. HO-1 is induced by oxidant stress and plays a crucial role
in protection against oxidative insult in diabetes and cardiovascu-
lar disease [7,30]. A potential function of HO-1 in cardiomyocytes
was suggested when primary rat neonatal cardiomyocytes
responded to hypoxia with increased expression levels of protein
and of HO-1 mRNA, while under normal physiological condi-
tions, HO-1 is expressed at low levels in cardiomyocytes [31].
CoPP, an inducer of HO-1, protects human cardiac stem cells
against apoptosis through the activation of the ERK/Nrf2
signaling pathway [32]. HO-1 induction also enhances cell
survival and restores contractility in adult cardiomyocyte grafts
implanted in mice [33]. Our aim in this study was to characterize
the protective capability of HO-1 induction in rat cultured
cardiomyocytes exposed to hypoxic stress and in diabetic mice
subjected to LAD ligation. We also wished to elucidate the possible
mechanisms which provide cardioprotection. There was a direct
correlation between HO-1 over expression and cardiac protection.
Our results in the in vitro study demonstrate that HO-1
induction protects cardiomyocytes against hypoxic stress. CoPP
treatment in hypoxic cells reduced cell damage as measured by
lower levels of LDH and CK, maintained cell morphology and
increased the viability of cardiomyocytes following hypoxia, as
seen by propidium iodide (PI) staining. CoPP also preserved
mitochondrial membrane potential. Mitochondrial membrane
potential depolarization is an early event in the intrinsic apoptotic
pathway activated by hypoxia. Inhibition of HO activity by SnPP
abolished the beneficial effect of CoPP-pretreatment in the
Figure 4. Changes in fractional shortening and left ventricle dimensions in Diabetic Mice. A: LV end-systolic diameters 24 hour post -MI.
The LV end-systolic diameter increased in diabetic mice compared with non-diabetic values (*p,0 05 vs. non diabetic # p,0.05 vs. diabetes values
are presented as means 6 SD). B: Fractional shortening (FS): CoPP treatment increased FS compared to the untreated diabetic ones SnPP abolished
the beneficial effect (*p,0.05 vs. non diabetic # p,0.01 vs. diabetes, $ p,0.05 vs. diabetes + CoPP values are presented as means 6 SD; n = 7 in
control and CoPP group; n = 5 in other groups values are presented as means 6 SD).
doi:10.1371/journal.pone.0092246.g004
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cardiomyocyte culture subjected to hypoxia. Dual control
mechanisms exist for metalloporphyrins as exemplified by SnPP,
which potently inhibits HO activity while increasing the content of
HO protein in the liver [34]. In the SnPP treated cells an increase
in protein level was observed in conjunction with the abolition of
the protective effects of CoPP.
Our study in mice investigated and characterized for the first
time the protective capability of HO-1 induction in diabetic mice
subjected to LAD ligation. This study demonstrates the beneficial
effects of HO-1 after cardiac remodeling induced by MI. Because
HO-1 levels are lower in diabetic patients [12] we examined the
influence of HO-1 induction on damage to the heart in diabetic
mice following LAD ligation. CoPP improved cardiac function as
seen by increased FS, reduced infarct size and biochemical
markers of myocardial injury in diabetic mice after LAD ligation.
HO-1 is a rapidly inducible cytoprotective protein that degrades
heme to biliverdin, ferrous iron, and carbon monoxide (CO) [8],
[9]. HO-1 plays an important role in maintaining redox status
within the heart, and protects the vital organ against oxidative
insult. In our diabetic mice, we observed that CoPP treatment
decreased oxidative stress as seen by lower levels of superoxide.
HO-1 also increased the levels of adiponectin. The increase in
adiponectin was associated with a significant decrease in TNF-a
[13]. The dysfunction of adipose tissue, characterized by the
infiltration of inflammatory cells and the aberrant production of
adipokines, is a key link between obesity and cardiovascular
disease [35,36]. Adiponectin is one of the few adipokines that
possesses multiple salutary effects on the prevention of cardiovas-
cular disease [37]. Adiponectin directly affects signaling in
myocardial cells and exerts beneficial activities on the heart after
pressure overload and ischemia–reperfusion injury [20,21,22].
Adiponectin-deficient mice showed increased infarct size after
ischemia-reperfusion. Exogenous adiponectin reduced infarct size
in both adiponectin-deficient and wild-type mice [19].Sharma et
al., showed that ischemia/reperfusion substantially enhances HO-
1 expression in the porcine heart, suggesting a potential role of
HO-1 in the defense against pathophysiological stress [38]. The
HO-1-mediated protection from myocardial ischemia/reperfusion
Figure 5. HO-1 induction reduces myocardial ischemia injury in Diabetic Mice. A, B: Measurements of biochemical markers in CoPP
pretreated mice compare with untreated The release of troponin T and CK to the serum 24 h post LAD ligation was lower in the diabetic mice treated
with CoPP compared with untreated diabetic mice. n = 6 mice/group Values are means 6 SD (Troponin T, $ p,0.005 vs. sham non diabetes/sham
diabetes,*p,0.05 vs. non diabetes MI, #p,0.01 vs. diabetes MI, + p,0.05 vs. diabetes + CoPP, CK $p,0.005 vs. Sham non diabetes/sham
diabetes,*p,0.05 vs. non diabetes MI, #p,0.01 vs. diabetes MI, + p,0.05 vs diabetes +CoPP) C: Infract size by TTC staining: Hearts were isolated at
24 hours after MI and stained with TTC for the measurement of infarct area. Viable part of the heart appears red and the infarct area white.
Quantification of the infarct area shows that the infarct area is significantly smaller in CoPP treated diabetic mice compared to untreated diabetic
mice. Values are means 6 SD; n = 6 mice/group (*p,0.05 vs. non diabetes MI, #p,0.05 vs. diabetes MI).
doi:10.1371/journal.pone.0092246.g005
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injury was associated with a decrease in oxidative stress and pro-
apoptotic and pro-inflammatory protein levels [39]. In experi-
mental diabetes models, overexpression of HO-1 prevented
vascular dysfunction [11] and attenuated oxidative stress-depen-
dent endothelial cell damage [40]. HO-1 overexpression promoted
neovascularization and ameliorated apoptosis in a heart failure
model [30]. Our study and those of others, clearly demonstrate
that over expression of HO-1 in the cardiomyocyte protects
against ischemia injury, thus improving cardiac function.
The mechanism(s) underlying the cardioprotective actions of
HO-1 have not been fully elucidated. The cytoprotective
properties of HO-1 have been attributed to the degradation of
heme and the beneficial effects of its by-products, bilirubin and
carbon monoxide (CO). Cells overexpressing HO-1 exhibit low
levels of free iron because of the upregulation of ferritin and the
extraction of iron into the extracellular space [41,42]. The
byproducts of heme degradation (bilirubin, CO, and iron as
ferritin) exert actions that protect the cell from oxidative damage
and death. HO-1 may also exert cytoprotective effects, indepen-
dent of heme breakdown [43] by interacting with survival
signaling pathways. HO-1 elevated adiponectin levels are associ-
ated with increased heart eNOS and pAKT levels, both of which
increase resistance to oxidants and cell survival [10]. HO-1
improved myocardial perfusion in diabetic mice by the up-
regulation of pLKB1 and AMPK signaling [44]. In the present
report, we examined a novel mechanism for cardioprotective
activity in cultured cardiomyocytes subjected to hypoxia. Our
results indicate that an increase in AKT activity is crucial for the
increased levels of HO-1 induced protection against hypoxia
induced injury. CoPP treatment, in cardiomyocyte cultures before
hypoxia, raised pAKT expression resulting in phosphorylation and
inactivation of GSK3b (ser 9). Phosphorylation at this site
inhibited the activation of GSK3-b, leading to decreased mPTP
opening followed by an increase in cardiomyocyte protection [45].
Figure 6. HO-1 induction increases HO-1, AKT and GSK3b expression in diabetic hearts. A:CoPP treatment significantly increased HO-1
expression levels (Means 6 SD, n = 5. $p,0.005 vs. sham, *p,0.01 vs. diabetes,). B: Western blot analysis of AKT and p-AKT and p-Akt/Akt ratio in the
different groups. CoPP treatment increased p-Akt levels while SnPP decreased the expression of p-AKT compared to the CoPP treated diabetic mice.
(Means6SD, n = 5. $,0.05 vs. sham,*p,0.05 vs. diabetes, #p,0.05 vs. diabetes+CoPP C: Western blot analysis of GSK-3b in mice subjected to LAD
ligation. CoPP treatment led to an increase in GSK-3b levels; SnPP decreased GSK-3b expression compared to the CoPP treated diabetic mice (Means
6 SD, n = 5. $,0.05 vs. sham, * p,0.05 vs. diabetes, #p,0.05 vs. diabetes+CoPP).
doi:10.1371/journal.pone.0092246.g006
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Pore opening results in mitochondrial dysfunction with uncoupled
oxidative phosphorylation and ATP hydrolysis, ultimately leading
to cell death. Thus, mPTP is a critical therapeutic target for both
pharmacological and conditional strategies to block pore forma-
tion [46]. Our results demonstrate that the protective effect that
results from the induction of HO-1 is via activation of the AKT
pathway, inhibition of GSK3b and protection of the mitochondria
and its function in cardiomyocytes subjected to hypoxia. We
hereby illustrate that in cardiomyocyte cultures CoPP preserves
the mitochondrial membrane potential. Ischemic preconditioning
preserves mitochondrial membrane potential and limits reactive
oxygen species production in rat hearts [47]. SnPP decreased HO
activity thereby preventing the activation of pAKT and the
protective effect on the mitochondria seen with CoPP. The in vivo
result (diabetic mice subjected to MI) supports the findings of the
culture study. Our results indicate that HO-1 induction increases
AKT activity in the heart of diabetic mice in a MI model; they are
partly protected against hypoxia induced injury. The activation of
this pathway enables cells to survive by the inhibition of
proapoptotic signals and the induction of survival signals. In the
treated diabetic mice AKT activation also phosphorylated and
inactivated GSK3b (ser 9) inducing cardioprotection [45].
The activation of this pathway enables cells to survive by the
inhibition of proapoptotic signals and by the induction of survival
signals. We examined the expression of survival-promoting Bcl-2
and found a higher level of Bcl-2 protein expression in CoPP
treated diabetic animals compared to the non-treated diabetic
mice. This result indicates that increased HO-1 levels contribute to
the activation of Bcl-2. Bcl-2 is up-regulated at the acute stage
(expressed soon after the onset of infarction) suggesting that Bcl-2
protects cardiomyocytes against apoptosis. The up-regulation of
Bcl-2 by CoPP in diabetic mice is important in order to limit
apoptosis in the areas surrounding the infarct and to decrease
damage to the heart immediately after MI.
In conclusion, we provide novel evidence that increased levels of
HO-1 protects cardiomyocytes against hypoxia and reduces
cardiac damage in diabetic mice subjected to LAD-ligation.
HO-1 induction increases the AKT prosurvival pathway. The
activation of AKT and inhibition of GSK-3b (believed to preserve
the mitochondrial membrane potential (DYm)) in hypoxia induces
cytoprotection in cardiac myocytes and in diabetic mice with MI.
Increased levels of HO-1 ameliorate apoptosis and necrotic cell
death as seen by enzyme release and a decrease in the levels of
apoptotic markers. Levels of adiponectin (cardioprotective) are
increased while the level of the inflammatory cytokine TNFa
Figure 7. Anti-apoptotic effects of HO-1 on cardiomyocytes in diabetic mice. A: Western blot analysis of Bax B: Bcl-2 C: and Bcl-2/Bax ratio,
in mice subjected to LAD ligation. CoPP treatment increased the levels of Bcl-2 expression but it did not change Bax expression to shift the Bcl-2/Bax
ratio towards the antiapoptotic Bcl-2 (Means 6 SD, n = 5. *p,0.05 vs. diabetes+MI, #p,0.05 vs. diabetes+CoPP, Table, *p,0.05 vs. diabetes+MI, #
p,0.05 vs. diabetes+CoPP).
doi:10.1371/journal.pone.0092246.g007
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(cardiodepressant) are decreased. Therefore, the use of either a
pharmacological preconditioning agent or gene transfer to
increase HO-1 levels may provide a therapeutic approach to the
development of cardioprotection in humans and the enhancement
of recovery and repair of the heart post-MI in CAD patients.
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